SMA Screening ISE Partnership Board update February 2025

An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
The latest meeting of the SMA Screening In-service evaluation Partnership Board heard that interim results of a new modelling study into SMA screening for the UK context had been presented to a stakeholder workshop.
Oversight group gets to work in following up UK NSC’s recommendation for the implementation of newborn screening for Hereditary Tyrosinaemia Type 1.
Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
In 2016 the UK National Screening Committee (UK NSC) was piloting a new approach for reviewing existing screening programmes.
Professor Anne Mackie reflects on 2015 calling it 'a particularly exciting year for screening'.